Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

The solution provides essential ions that replace those removed by the dialysis membrane. Sodium and chloride maintain osmotic pressure, potassium and calcium support cardiac and neuromuscular function, and bicarbonate buffers excess hydrogen ions, correcting metabolic acidosis and stabilising blood pH during treatment.

The dose of Multibic is determined by the prescribing clinician based on the patient’s individual dialysis prescription, electrolyte profile and fluid requirements. No fixed regimen is provided; the healthcare professional sets the infusion volume and rate appropriate for each treatment session.

Limited clinical data are available for use of Multibic in pregnant or lactating women. It should only be administered if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Multibic, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with standard bicarbonate‑based dialysis fluids, Multibic offers a broader electrolyte profile that includes potassium and calcium in addition to sodium, chloride and bicarbonate. This can simplify formulation for centres that need to adjust multiple electrolytes simultaneously, though clinicians must monitor for potential electrolyte overload.

Multibic should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the container in its original packaging to maintain sterility and prevent temperature excursions during transport or storage.

Multibic is administered intravenously as part of the haemodialysis circuit. It is added to the dialysis fluid line or infused directly into the patient’s bloodstream according to the prescribed rate and volume, typically under the supervision of a trained dialysis nurse or physician.

The most serious risks include severe hyperkalemia, metabolic alkalosis, and rare anaphylactic reactions. Continuous monitoring of serum electrolytes and arterial blood gases during treatment helps detect these complications early and allows prompt intervention.

Multibic is contraindicated in patients with uncontrolled hyperkalemia, severe metabolic alkalosis, or known hypersensitivity to any of its components. Caution is also advised for individuals on high‑dose potassium supplements or other bicarbonate‑rich solutions.